John E Davis Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 3 days, 11 hours ago
John E Davis has an estimated net worth of at least $10.7 million*, as of Sept. 3, 2025. They own 208,778 shares of AORT stock. They have sold 57,215 shares of AORT stock since 2021, for an estimated $1.5 million.
John E Davis $AORT SEC Form 4 Insider Trading
John E Davis has filed a total of 15 insider trades in $AORT since 2021. Their most recent trade was a sale of 10,802 shares, made on Aug 12, 2025. Their largest trade was a sale of 15,100 shares, made on Mar 11, 2025. We estimate that they now own 208,778 shares of $AORT, worth an estimated $9.2 million.
Insider Trading at $AORT
There have been a total of 161 insider trades reported at $AORT since 2021, with 0 shares purchased and 885,656 shares sold. The most active insider traders in $AORT stock have been Jean F Holloway, James P Mackin, and Marshall S. Stanton. The most recent trade was a sale of 18,200 shares reported by Marshall S. Stanton (SVP, Clinical & MD Affair), made on Aug 27, 2025.
History of Insider Stock Trades by John E Davis
| Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
|---|---|---|---|---|
AORT
|
Sale | 10,802 | Aug 12, 2025 | Aug. 14, 2025, 9:56 a.m. |
|
AORT
|
Sale | 15,100 | Mar 11, 2025 | March 12, 2025, 3:32 p.m. |
|
AORT
|
Sale | 2,618 | Mar 06, 2025 | March 10, 2025, 5:06 p.m. |
|
AORT
|
Sale | 2,846 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 2,035 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 591 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 985 | Feb 24, 2025 | Feb. 26, 2025, 2:54 p.m. |
|
AORT
|
Sale | 2,022 | Mar 05, 2024 | March 7, 2024, 7:14 p.m. |
|
AORT
|
Sale | 584 | Feb 27, 2024 | Feb. 29, 2024, 6:32 p.m. |
|
AORT
|
Sale | 496 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
AORT
|
Sale | 2,060 | Feb 20, 2024 | Feb. 22, 2024, 6:32 p.m. |
|
AORT
|
Sale | 13,562 | Jan 02, 2024 | Jan. 4, 2024, 5:22 p.m. |
|
AORT
|
Sale | 1,121 | Mar 02, 2023 | March 3, 2023, 6:52 p.m. |
|
AORT
|
Sale | 1,185 | Feb 27, 2023 | March 1, 2023, 7:44 p.m. |
|
AORT
|
Sale | 1,208 | Feb 27, 2023 | March 1, 2023, 7:44 p.m. |
CRY
|
Purchase | 600 | Nov 29, 2021 | Dec. 1, 2021, 5:14 p.m. |
$AORT Executives and Stock Owners with Insider Trades
-
Jean F Holloway, SVP, General Counsel
-
James P Mackin, President & CEO
-
Marshall S. Stanton, SVP, Clinical & MD Affair
-
Amy Horton, VP, Chief Accounting Officer
-
Matthew A Getz, VP, Human Resources
-
John E Davis, Chief Commercial Officer
-
Andrew M Green, VP Regulatory
-
Dennis B Maier, SVP, Operations
-
Rochelle L. Maney, VP, Quality
-
David Ashley Lee, Executive VP, COO & CFO
-
John E Davis, Senior VP, Global Sales
-
Florian Tyrs, VP, Global Operations
-
Lance A Berry, Executive VP, CFO
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.